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Preventing and Controlling Oral
and Pharyngeal Cancer
Recommendations from a National
Strategic Planning Conference
Summary
In August 1996, CDC convened a national conference to develop strategies for
preventing and controlling oral and pharyngeal cancer in the United States. The
conference, which was cosponsored by the National Institute of Dental Research
of the National Institutes of Health and the American Dental Association, in-
cluded 125 experts in oral and pharyngeal cancer prevention, treatment, and
research; both the private and public sectors were represented. Participants at
the conference developed recommendations concerning advocacy, collabora-
tion, and coalition building; public health policy; public education; professional
education and practice; and data collection, evaluation, and research.
A follow-up meeting consisting of selected participants of the 1996 confer-
ence was held in September 1997. During this meeting, changes that had
occurred in the political and scientific arenas since the 1996 conference were
considered, and 10 recommended strategies from the conference were selected
for priority implementation. These 10 strategies were to a) establish a mecha-
nism to implement and monitor the recommended strategies developed during
the conference; b) urge oral health professionals to become more actively in-
volved in community health; c) require instruction in preventing and controlling
tobacco and alcohol use at all levels of training in dental, medical, nursing, and
other related health-care disciplines; d) encourage Medicaid, Medicare, tradi-
tional insurance plans, and managed-care entities to consider making oral
cancer examinations an integral part of comprehensive physical and oral exami-
nations; e) designate federal funding for a national program of oral cancer
prevention, early detection, and control; f) after assessing local needs, develop,
implement, and evaluate statewide models to educate all relevant groups; g)
develop and conduct a national promotional campaign to raise public aware-
ness of oral cancer and its link to tobacco use and heavy alcohol consumption;
h) develop health-care curricula that require competency in prevention, diagno-
sis, and multidisciplinary management of oral and pharyngeal cancer; i) sponsor
and promote continuing education for health-care professionals on the multidis-
ciplinary management of all phases of oral cancer and its sequelae; and j)
strengthen organizational approaches to reducing oral cancer by developing or-
ganized cooperative and collaborative arrangements, funding formal centers,
and involving commercial firms.
CDC will use these recommended strategies to develop programs to reduce
the burden of oral and pharyngeal cancer in the United States. Through the Oral
Cancer Roundtable, a group of conference and meeting participants, CDC will
communicate to interested agencies, organizations, and state health depart-
ments ways in which they can implement elements of the national plan. The
Roundtable will help CDC track the efforts and progress of these groups.
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INTRODUCTION
During the past decade, federal health agencies have focused on reducing the inci-
dence of oral and pharyngeal cancer and increasing the 5-year survival rate from
these cancers in the United States. Beginning with a consortium of health agencies in
1992 (and including a strategic planning conference in 1996 and a follow-up meeting
in 1997), CDC has been involved in concerted efforts to establish a national plan for
preventing and controlling these cancers. This report presents recommended strate-
gies for action from the 1996 conference and a list of priority recommendations from
the 1997 meeting. These recommendations will enable CDC to develop a coordinated
national plan to reduce morbidity and mortality from oral and pharyngeal cancer in
the United States.
ORAL AND PHARYNGEAL CANCER
Oral cancer (i.e., cancer of the lip, tongue, floor of the mouth, palate, gingiva and
alveolar mucosa, buccal mucosa, or oropharynx)* accounts for 2%–4% of cancers di-
agnosed annually in the United States; approximately two thirds occur in the oral
cavity, and the remainder occurs in the oropharynx (1 ). In 1998, this diagnosis will be
made in an estimated 30,300 Americans; approximately 8,000 deaths (5,200 males and
2,800 females) are expected in this year (2 ). Ninety-five percent of cases of oral cancer
occur among persons aged >40 years, and the average age at diagnosis is 60 years
(3). In 1950, the male-to-female ratio of oral cancer incidence was approximately 6:1;
by 1997, it was approximately 2:1. The changing ratio is likely the result of the increase
in smoking among women in the past three decades (3 ). In addition, cancer is an
age-related disease, and in the United States, the number of women aged >65 years
now exceeds the number of men aged >65 years by almost 50% (3 ). During 1990–
1994, the annual incidence rate among black males in the United States was 1.6 times
higher than the rate among white males (20.1 versus 12.9 new cases per 100,000) and
the annual mortality rate among black males was 2.5 times higher (7.6 versus 3.1
deaths per 100,000); the annual incidence rate among black females was slightly
higher than that among white females (5.6 versus 4.9 new cases per 100,000), as was
the annual mortality rate (1.8 versus 1.2 deaths per 100,000) (4 ). Despite agressive
combinations of surgery, radiation therapy, and chemotherapy, the 5-year survival
rate for oral cancer is poor (blacks: 35%; whites: 55%) (1,5 ).
Tobacco smoking (i.e., cigarette, pipe, or cigar smoking), particularly when com-
bined with heavy alcohol consumption (i.e., ≥30 drinks per week), has been identified
as the primary risk factor for approximately 75% of oral cancers in the United States
(6 ) . The use of tobacco in other forms (i.e., snuff and chew) has also been identified
as a risk factor (7–9 ), as have certain other lifestyle and environmental factors (e.g.,
diet and occupational exposure to sunlight) (10 ).
Approximately 90% of oral cancer lesions are squamous cell carcinomas. Persons
who have oral cancer often develop multiple primary lesions (i.e., field cancerization),
and they develop second primary tumors at a rate of approximately 4% annually (11 ).
Persons having primary oral cancer are more likely to develop a second primary can-
cer of the aerodigestive tract (i.e., oral cavity, pharynx, esophagus, larynx, and lungs)
*Hereafter, pharyngeal cancer is also included in the term oral cancer.
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(12,13 ). The initally diagnosed disease accounts for one half of the deaths caused by
oral cancer; one fourth of these deaths are due to a second primary cancer, and the
remaining one fourth are attributable to other illnesses (13 ).
Diagnosing cancers at an early stage is crucial to improving survival rate and re-
ducing morbidity. At the time of diagnosis of oral cancer, 36% of persons have
localized disease, 43% have regional disease, and 9% have distant disease (for 12%
the disease is unstaged) (4 ). The 5-year survival rate for persons having oral cancer is
81% for those with localized disease, 42% for patients with regional disease, and 17%
for those with distant metastases (4 ). During the past decade, at diagnosis stage has
not changed significantly (3 ).
ORAL CANCER STRATEGIC PLANNING CONFERENCE
Background
In 1992, a consortium of health agencies led by CDC and the National Institute of
Dental Research (NIDR) of the National Institutes of Health began to establish goals,
objectives, and programs to reduce oral cancer morbidity and mortality in the United
States. The Oral Cancer Work Group, which was formed as part of this initiative, sub-
sequently developed short-term and long-term goals for preventing and controlling
oral cancer. A list of these goals was disseminated to interested organizations and
individuals in 1993.
One of the recommendations of the Oral Cancer Work Group was to summarize the
state of the science regarding oral cancer. In response, CDC commissioned nine back-
ground papers regarding the prevention, control, and treatment of the disease and
addressing current knowledge, emerging trends, opportunities, and barriers to further
progress. The authors, representing several specialties and expertise, drew on current
literature reviews, in-depth critiques, and personal experience.
The Oral Cancer Work Group also suggested that CDC convene a conference to
develop national strategies to help make oral cancer prevention and control a higher
public health priority. Subsequently, CDC, in partnership with NIDR and the American
Dental Association (ADA), formed a conference planning group. The planning group,
along with a larger cadre of oral cancer experts, developed a draft set of strategies.
This draft and the nine background papers were distributed to invited participants be-
fore the conference.
Conference Format
The Oral Cancer Strategic Planning Conference was held August 7–9, 1996, at the
ADA headquarters in Chicago. Participants included 125 invited experts in oral cancer
prevention, treatment, and research; both the private and public sectors were repre-
sented. Following brief welcoming remarks by ADA, CDC, and NIDR representatives,
nationally recognized experts made presentations on the etiology of oral cancer, its
epidemiology, ongoing and needed research, and clinical experience with five other
cancers (i.e., leukemia and breast, cervical, lung, and prostate cancers). A survivor of
oral cancer described the human impact of the disease.
Vol. 47 / No. RR-14 MMWR 3
Conference participants broke into five work groups: advocacy, collaboration, and
coalition building; public health policy; public education; professional education and
practice; and data collection, evaluation, and research. Each work group had a chair-
person and co-chairperson who were preselected from the conference participants;
toward the conclusion of the conference, chairpersons presented their work groups’
recommended strategies to all conference participants, who provided oral and written
feedback. The work groups made revisions, including comments raised during the
general session.
After the conference, the recommended strategies were disseminated to all partici-
pants for final review and comments. These last comments were incorporated to
produce the finalized recommended strategies to reduce oral cancer morbidity and
mortality in the United States.
Recommended Strategies from Work Groups
Advocacy, Collaboration, and Coalition Building
The work group on advocacy, collaboration, and coalition building (e.g., formation
by the oral health community of partnerships with other health professionals and pub-
lic or private organizations to facilitate increased awareness of the risk factors for oral
cancer) developed three main recommended strategies.
• Establish an ongoing, institutionalized mechanism to implement and monitor
progress made regarding the recommended strategies developed during the
conference.
• Urge professionals in oral health and other health disciplines to become more
actively involved in community health concerns, especially in preventing tobacco
and heavy alcohol use, by
– developing a comprehensive advocacy training program for a core group of
oral health professionals;
– recruiting persons from the health community and enrolling them in a national
database for tobacco and oral cancer advocacy;
– designing outreach programs to encourage local and state dental societies to
be proactive in oral cancer and related coalitions;
– establishing an advocacy network of oral cancer survivors; and
– developing a speakers bureau of sports figures and other prominent persons
willing to speak about risk factors for oral cancer and the importance of its
early detection.
• Promote the publication and dissemination of the U.S. Department of Health and
Human Services’ biennial Report to Congress on Tobacco Control Activities in the
United States. This document, mandated by the Comprehensive Smoking Educa-
tion Act of 1984 (14 ) and the Comprehensive Smokeless Tobacco Health
Education Act of 1986 (15 ), should review completely the health effects of and
trends in tobacco use. It should also serve as a tool to update policymakers, the
media, and the public on smokeless tobacco use and oral health.
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Public Health Policy
This work group presented its recommended strategies in four categories.
Prevention and Control of Tobacco and Alcohol Use.
• Increase excise taxes on tobacco and alcohol products to provide targeted fund-
ing for oral cancer prevention programs.
• Strengthen and enforce laws regarding youth access to tobacco and alcohol.
• Give the U.S. Food and Drug Administration regulatory authority over tobacco,
because nicotine is an addictive drug.
• Prohibit all advertising and promotional activities by the tobacco industry and
conduct a well-funded counteradvertising campaign that focuses on cigarettes,
cigars, pipe tobacco, and spit tobacco.
• Deny federal health and medical research funding to organizations that accept
health research funding from the tobacco industry or its research institutes.*
• Increase excise taxes on spit tobacco to an amount equal to or greater than the
taxes on cigarettes.
• Encourage professional sports teams to ban the use of tobacco products among
team members during practices and games.
• Add strong statements to tobacco and alcohol warning labels about the risk of
oral cancer. Ensure that tobacco warning labels cover 25%–30% of the front or
back of a product’s package and advertising copy. Model warnings after those
used in Australia and Canada.
Professional Knowledge and Behaviors.†
• Require instruction in preventing and controlling tobacco and alcohol use, in-
cluding tobacco cessation, at all levels of training in dental, medical, nursing, and
related health-care disciplines.
• Ensure that clinicians learn procedures to detect oral cancer that are appropriate
to their professional practice.
• Urge all health professionals to routinely assess tobacco and alcohol intake by
their patients.
• Encourage health-care agencies and professionals to recommend that all clini-
cians who deliver primary health care routinely examine their patients for oral
cancer.
§
*This strategy generated considerable discussion among the conference participants. The work
group recognized this strategy could negatively affect research support for oral cancer but still
recommended it.
†These strategies complement those developed by the work group on professional education
and practice but are listed here because of their implications for public policy.
§The U.S. Preventive Services Task Force states that “there is insufficient evidence to recom-
mend for or against routine screening of asymptomatic persons for oral cancer by primary
care physicians” but that “clinicians should remain alert to signs and symptoms of oral cancer
and premalignancy in persons who use tobacco and alcohol” (16 ). The work group, however,
believed that all persons should be routinely examined and chose a stronger recommendation.
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Compensation.
• Work with the ADA and the American Medical Association to reaffirm that exist-
ing codes for reimbursement (e.g., Common Procedure Terminology and
Common Dental Terminology) appropriately identify oral cancer examinations as
part of the standard oral examination.
• Encourage Medicaid, Medicare, traditional insurance plans, and managed-care
entities to make oral cancer examinations an integral part of comprehensive
physical and oral examinations.
• Base reimbursement for oral cancer examinations on the service provided rather
than the academic degree of the provider.
National Programs.
• Designate federal funding for a national program of oral cancer prevention, early
detection, and control that includes support for outcomes assessment and pol-
icy-based research.
Public Education
Seven major strategies were recommended by the work group on public educa-
tion.
• Develop and disseminate guidelines and lists of resources to assist communities
(e.g., states, counties, cities, towns, and members of organizations and institu-
tions) in developing, implementing, and evaluating models for oral cancer
education. This effort could include an inventory of available guidelines, litera-
ture, processes, and educational models.
• Develop, implement, and evaluate statewide models to educate all relevant
groups. These models should be tailored to local needs, practical, culturally ap-
propriate, and user friendly and should include the following content areas:
– risk factors for oral cancer (e.g., tobacco use, alcohol use, and nutritional defi-
ciencies);
– signs and symptoms of oral cancer;
– procedures for a thorough oral cancer examination and the ease with which
the examination can be performed; and
– methods of public advocacy.
• Pursuade relevant CDC and National Institutes of Health decisionmakers, mem-
bers of Congress, and members of other organizations to secure funding for
statewide oral cancer model demonstration projects and to establish an oral
health component in CDC’s Initiatives to Mobilize for the Prevention and Control
of Tobacco Use (IMPACT) program.
• Develop and conduct a national campaign to raise public awareness of oral can-
cer and its link to tobacco use and heavy alcohol consumption. The campaign
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might include a mascot or logo, sports figures or other distinguished persons as
spokespersons, or a national oral cancer awareness week.
• Ensure that behavioral and educational research in oral cancer is included in the
budget of organizations that sponsor such research (e.g., the National Institutes
of Health, universities, and foundations).
• Increase the representation of educators, behavioral scientists, and oral cancer
specialists on the grant review committees of cancer and dental research institu-
tions.
• Ensure that a national research agenda is developed that includes the following:
– ongoing surveillance to monitor knowledge, opinions, attitudes, and practices
of the public, especially populations at high risk for oral cancer;
– surveys of the knowledge, opinions, attitudes, and practices of relevant health-
care providers regarding oral cancer;
– evaluations of the effectiveness of educational interventions among targeted
populations;
– changes in existing survey instruments (e.g., the National Health Interview
Survey) to include items on oral cancer comparable to items on other cancers;
– inclusion of oral cancer questions in state Behavioral Risk Factor Surveillance
System surveys;
– determination of the proficiency of persons who have been taught to perform
an oral cancer self-examination; and
– assessment of the quality (e.g., reading level or scientific accuracy), quantity,
and availability of educational materials directed to the public about oral can-
cer.
Professional Education and Practice
This work group developed five recommended strategies.
• Develop health-care curricula that require competency in prevention, diagnosis,
and multidisciplinary management of oral cancer, including the prevention and
cessation of tobacco use and alcohol abuse.
• Promote soft tissue examination for oral cancer as a standard part of a complete
patient examination.
• Develop, promote, and maintain a database of all professional education materi-
als related to oral cancer.
• Define, identify, develop, and promote centers of excellence in oral cancer man-
agement.
• Sponsor and promote continuing education for health-care professionals on the
multidisciplinary management of all phases of oral cancer and its sequelae.
In addition, the work group identified seven initiatives that would facilitate achieve-
ment of their recommended strategies: develop educational standards and standards
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of care for oral cancer; standardize techniques for oral cancer examination and imple-
ment them consistently; create a national speakers bureau with standardized
educational materials; place an oral cancer home page on the World Wide Web; create
guidelines for developing screening and detection programs; develop self-instruc-
tional materials for health professionals on a range of topics (e.g., risk factors, early
detection, and counseling of high-risk patients); and identify and catalog professional
education materials, determine deficits in these materials, and ensure access to the
cataloged materials.
Data Collection, Evaluation, and Research
These recommended strategies would facilitate research regarding the etiology,
prevention, and treatment of oral cancer and would translate research findings into
effective public health action.
• Increase funding or target existing funding to initiate and sustain research con-
cerning oral cancer.
• Improve the capacity of individual health practitioners and small medical centers
to participate in research regarding prevention strategies and therapeutic ap-
proaches.*
• Develop curricula for basic preparation and continuing education for health pro-
fessionals that will improve their knowledge of the nature, value,
implementation, and importance of well-designed and well-conducted research
studies.
• Improve researchers’ access to tissues, study populations, and data sources.
Possible approaches include
– using population-based cancer registries for follow-up studies;
– combining information from state-based population-based cancer registries
and from national registries (e.g., the Surveillance, Epidemiology, and End Re-
sults [SEER] program) to help develop an enhanced descriptive epidemiology
of oral cancer, particularly for smaller subpopulations insufficiently repre-
sented in the SEER or state registries;
– encouraging the use of existing databases, either singly or in combination, to
address questions about oral cancer care, consequences, and costs (e.g., one
such database combines SEER incidence and survival data for Medicare bene-
ficiaries with their Medicare claims data);
– developing a systematic approach to providing researchers with access to tis-
sue specimens and detailed information about the behavioral and medical
characteristics of persons who are at high risk for oral cancer, have premalig-
nant lesions, or currently have oral cancer; finding creative ways to share
* This strategy would facilitate execution of multicenter studies, which are often needed to
produce highly generalizable findings and to provide adequate statistical power to detect
relatively small differences. It also recognizes the growing trend toward treating oral cancer
in ambulatory settings and within managed-care delivery systems. Differences in treatment
outcomes for all the major delivery systems and settings cannot be assessed completely if
physicians’ and dentists’ offices are not included in research studies of small medical centers.
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appropriate biopsy specimens, research subjects and patients, and research
findings so that researchers can maximize the information gained from bio-
logical studies; and developing laboratory assays that conserve specimens,
thus allowing for multiple assessments of the same tissue; and
– evaluating innovative approaches for identifying persons at greatest risk for
oral cancer and recruiting them for research studies (e.g., form partnerships
with organizations serving residents of homeless shelters or clients of alcohol
treatment centers).
• Develop valid and reliable patient-oriented indices of health, quality of life, and
functioning.
• Obtain input from affected groups (e.g., persons who are the subjects of re-
search, surveillance, or treatment; professional-school students; and clinical
practitioners) about how research or training in research can best be accom-
plished. Conduct focus groups and gather other information to refine research
questions and formulate effective ways to obtain responses, cooperation, and
compliance from research subjects.
• Create multidisciplinary groups to facilitate movement of findings in two direc-
tions—from basic research to applied research and from research in the clinical
sciences, epidemiology, and health-services delivery to basic science—thus help-
ing to focus basic research efforts. Such strategies may include the following:
– developing innovative science transfer techniques (e.g., Internet applications)
for researchers, clinicians, and the public;
– develop effective means of communicating the complex biological processes
to clinicians, students, and the public; and
– increasing research on how health-care practitioners and the public under-
stand and act on the concept of risk of a disease and its consequences.
• Strengthen organizational approaches to reducing oral cancer by developing co-
operative and collaborative arrangements, funding formal centers, and involving
commercial firms. The following means are suggested:
– consortia of researchers and medical and dental practitioners could share pa-
tient sources, standardize clinical protocols, achieve adequate sample sizes,
recruit patients and at-risk persons for research studies, and enhance science
transfer; individual practitioners as well as organizations (e.g., alcohol treat-
ment centers) that serve populations at risk for oral cancer or its sequelae
could be sources of study subjects;
– other formal centers could be established in addition to those funded by NIDR
and the National Cancer Institute; and
– commercial firms could use their marketing and distribution systems to en-
hance science transfer, health promotion, and disease prevention activities; in
addition, they could join with academic or government groups to fund or oth-
erwise facilitate research.
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ORAL CANCER WORKING GROUP
The Oral Cancer Working Group, a multidisciplinary group who attended the 1996
Oral Cancer Strategic Planning Conference, met September 29–30, 1997, to identify 10
strategies from the 1996 meeting recommendations to receive immediate attention
and implementation by the agencies they represented. The Oral Cancer Working
Group considered political and scientific changes that had occurred after the 1996
conference (e.g., the U.S. Food and Drug Administration had been given regulatory
authority over tobacco, legal cases involving tobacco had been settled in several
states, national tobacco legislation had been proposed, and four comprehensive oral
cancer research centers had been funded by NIDR) and selected strategies the group
could effect (as opposed to strategies already under way as a result of the leadership
and support of other groups). Leadership at the 1997 meeting was shared by repre-
sentatives of ADA, the American Association of Dental Research, the Association of
State and Territorial Dental Directors, CDC, the International Society of Oral Oncology,
NIDR, and Oral Health America. The 10 priority strategies are as follows.
Advocacy, Collaboration, and Coalition Building
• Establish a mechanism to implement and monitor progress made regarding the
recommended strategies developed during the 1996 national conference.
• Urge oral health professionals to become more actively involved in community
health concerns.
Public Health Policy
• Require instruction in preventing and controlling tobacco and alcohol use at all
levels of training in dental, medical, nursing, and related health-care disciplines.
• Encourage Medicaid, Medicare, traditional insurance plans, and managed-care
entities to make oral cancer examinations an integral part of comprehensive
physical and oral examinations.
• Designate federal funding for a national program of oral cancer prevention, early
detection, and control.
Public Education
• After assessing local needs, develop, implement, and evaluate statewide models
to educate all relevant groups.
• Develop and conduct a national campaign to raise public awareness of oral can-
cer and its link to tobacco use and heavy alcohol consumption.
Professional Education and Practice
• Develop health-care curricula that require competency in prevention, diagnosis,
and multidisciplinary management of oral cancer.
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• Sponsor and promote continuing education for health-care professionals on the
multidisciplinary management of all phases of oral cancer and its sequelae.
Data Collection, Evaluation, and Research
• Strengthen organizational approaches to reducing oral cancer by developing co-
operative and collaborative arrangements, funding formal centers, and involving
commercial firms.
At the 1997 follow-up meeting, the Oral Cancer Working Group created a smaller
group known as the Oral Cancer Roundtable. Members of the Roundtable will com-
municate among themselves to discuss implemention of the priority recom-
mendations and the recommendations from the 1996 conference and to share infor-
mation on progress made. Through the Roundtable, CDC will communicate to
interested agencies, organizations, and state health departmets ways in which they
can implement elements of the national plan. The Roundtable will help CDC track the
efforts and progress of these groups.
CONCLUSION
National efforts to reduce morbidity and mortality associated with oral cancer must
focus on two areas: primary prevention (i.e., reducing risk factors) and early detection.
Although persons at high risk for the disease are more likely to visit a physician than
a dentist, physicians may be less likely than dentists to perform an oral cancer exami-
nation on such patients (17–21 ). Thus, all primary-care providers must assume more
responsiblity for counseling patients about behaviors that put them at risk for devel-
oping this cancer, examining patients who are at high risk for developing the disease
because of tobacco use or excessive alcohol consumption (22 ), and referring patients
to an appropriate specialist for management of a suspicious oral lesion. Comprehen-
sive education of medical and dental practitioners in diagnosing and promptly
managing early lesions could facilitate the multidisciplinary collaboration necessary
to detect oral cancer in its earliest stages. Furthermore, because of the public’s lack of
knowlege about the risk factors for oral cancer and because this disease can often be
detected in its early stages (21,23 ), the public’s awareness of oral cancer (including its
risk factors, signs, and symptoms) must also be increased.
Oral cancer occurs in sites that lend themselves to early detection by most primary
health-care providers and, to a lesser extent, by self-examination. Heightened aware-
ness in the general population could help with early detection of this cancer and could
stimulate dialogue between patients and their primary health-care providers about
behaviors that may increase the risk for developing oral cancer. Recent advances in
understanding the molecular events involved in developing cancer might provide the
tools needed to design novel preventive, diagnostic, prognostic, and therapeutic regi-
mens to combat oral cancer. Acquiring greater knowledge of the biology, immu-
nology, and pathology of the oral mucosa may also help to reduce the morbidity and
mortality from this disease.
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